Capstone Investment Advisors
NVAX icon

Capstone Investment Advisors’s Novavax NVAX Stock Holding History

Capstone Investment Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,500
Closed -$265K – 1779
2025
Q4 		$265K Hold
39,500
– – ﹤0.01% 1410
2025
Q3 		$342K Hold
39,500
– – ﹤0.01% 1592
2025
Q2 		$249K Hold
39,500
– – ﹤0.01% 1469
2025
Q1 		$253K Sell
39,500
-100
-0.3% -$827 ﹤0.01% 1228
2024
Q4 		$318K Hold
39,600
– – ﹤0.01% 1464
2024
Q3 		$500K Hold
39,600
– – ﹤0.01% 1212
2024
Q2 		$501K Buy
39,600
+18,000
+83% +$181K ﹤0.01% 1308
2024
Q1 		$103K Sell
21,600
-417,000
-95% -$1.93M ﹤0.01% 2134
2023
Q4 		$2.11M Buy
438,600
+100
+0% +$612 0.01% 781
2023
Q3 		$3.17M Hold
438,500
– – 0.01% 566
2023
Q2 		$3.26M Buy
438,500
+204,700
+88% +$1.61M 0.02% 496
2023
Q1 		$1.62M Buy
+233,800
New +$2.15M 0.01% 650

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capstone Investment Advisors's NVAX Position: Q4 2024 in Review

Capstone Investment Advisors sold out of Novavax (NVAX) in Q4 2024, closing a stake of 3,360 shares — an estimated $32.4K sold.

Capstone Investment Advisors first reported a position in NVAX in Q3 2016 and held it in 7 quarters. The position peaked at $393K in Q3 2016. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

  • Capstone Investment Advisors reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 3,360 Novavax shares in Q4 2024, an estimated $32.4K.
  • Capstone Investment Advisors first reported a position in Novavax in Q3 2016 and held it in 7 quarters.
  • Capstone Investment Advisors's Novavax position peaked at $393K in Q3 2016.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Capstone Investment Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.